Viewing Study NCT03029533


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-06-08 @ 4:47 PM
Study NCT ID: NCT03029533
Status: UNKNOWN
Last Update Posted: 2017-01-24
First Post: 2017-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer
Sponsor: Daewoong Pharmaceutical Co. LTD.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module